A Remotely Delivered CBT Intervention for Youth With cSLE: A Multi-site Patient-engaged Investigation
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Michigan State University
- Enrollment
- 65
- Locations
- 4
- Primary Endpoint
- Retention rates of the study
Study Overview
Brief Summary
This study aims to investigate the feasibility and effectiveness of a remotely delivered psychological intervention for youth with cSLE. This intervention aims to teach participants skills in order to cope with fatigue, pain, and depressive symptoms--symptoms that commonly affect adolescents and young adults with lupus.
Detailed Description
This project is investigating whether a remotely delivered psychological intervention is acceptable and beneficial to teens and young adults coping with cSLE. This study uses a cognitive behavioral therapy (CBT) intervention called the Treatment and Education Approach for Childhood-onset Lupus (TEACH) to address symptoms of fatigue, depression, and pain that commonly occur in individuals with cSLE. The TEACH program includes six-weekly, one hour sessions, conducted over HIPAA-compliant video conferencing.
Participation in this study will take approximately 8-15 weeks, with a follow-up survey occurring 3-months after post-assessment, and a long-term follow-up survey occurring between 12-27 months after post-assessment. After qualifying for the study, participants will be randomly selected, like flipping a coin, to the TEACH program plus medical treatment as usual (TAU) OR medical TAU alone for six weeks. After this six-week time period, a post-assessment will be completed. Participants that only continued medical TAU will then be eligible to receive TEACH after completing the post-assessment. If these participants choose to undergo the TEACH treatment, they will be asked to complete a short interview about the program and answer questions about how their mood, pain, and fatigue.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Ages
- 12 Years to 22 Years (Child, Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Participants must be diagnosed with cSLE, meeting the revised American College of Rheumatology Classification Criteria for SLE by age 18 years
- •Participants must have at least one elevation (based off of screening measures) in fatigue, or depressive symptoms, or pain
- •Patient participants must have English language proficiency
- •For participants under age 18, must have a primary caregiver willing to participate.
Exclusion Criteria
- •Patients with other chronic medical conditions (e.g., juvenile arthritis),
- •Patients with a documented developmental delay, severe cognitive impairment, or thought disorder
- •Patients with an untreated major psychiatric illness (e.g., bipolar disorder, psychosis, severe depression, or active suicidal ideation)
- •Patients currently receiving psychological treatment for depression, fatigue or pain will be excluded to prevent overlapping treatments that may confound outcomes.
Outcomes
Primary Outcomes
Retention rates of the study
Time Frame: After data collection period, approximately 2 years
Retention rates will be measured by the number of participants who complete the study. This information will be collected after the data collection period ends.
Recruitment rates of the study
Time Frame: After enrollment period, approximately 2 years
Recruitment rates will be measured by the number of participants who agree to participate in the study. This information will be collected after the enrollment period.
Feasibility of remotely-delivered TEACH
Time Frame: Approximately 8 weeks
Feasibility will be measured by participant feedback in a qualitative interview.
Secondary Outcomes
- Long-term changes in fatigue, as measured by the PROMIS Fatigue SF(Between 20 and 32 weeks, and 12-27 from post-assessment)
- Changes in fatigue, as measured by the PROMIS Fatigue SF(Approximately 8 weeks)
- Changes in depressive symptoms, as measured by the Children's Depression Inventory-2 (CDI-2) and Beck Depression Inventory-II (BDI-II)(Approximately 8 weeks)
- Long-term changes in depressive symptoms, as measured by the Children's Depression Inventory-2 (CDI-2) and Beck Depression Inventory-II (BDI-II)(Between 20 and 32 weeks, and 12-27 from post-assessment)
Investigators
Natoshia Cunningham
Assistant Professor
Michigan State University